SHARPS TECHNOLOGY INC (STSS)
US82003F1012 - Common Stock
We assign a fundamental rating of 1 out of 10 to STSS. STSS was compared to 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of STSS is average, but there are quite some concerns on its profitability. STSS has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year STSS has reported negative net income.
In the past year STSS has reported a negative cash flow from operations.
In the past 5 years STSS always reported negative net income.
STSS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -69.94%, STSS is not doing good in the industry: 75.27% of the companies in the same industry are doing better.
STSS's Return On Equity of -120.99% is on the low side compared to the rest of the industry. STSS is outperformed by 67.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -69.94% | ||
| ROE | -120.99% | ||
| ROIC | N/A |
ROA(3y)-67.22%
ROA(5y)-123.74%
ROE(3y)-106.86%
ROE(5y)-159.66%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
STSS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
STSS has less shares outstanding than it did 1 year ago.
There is no outstanding debt for STSS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
STSS has an Altman-Z score of -5.62. This is a bad value and indicates that STSS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of STSS (-5.62) is worse than 72.58% of its industry peers.
STSS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.62 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
STSS has a Current Ratio of 1.01. This is a normal value and indicates that STSS is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.01, STSS is not doing good in the industry: 92.47% of the companies in the same industry are doing better.
STSS has a Quick Ratio of 1.01. This is a bad value and indicates that STSS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.57, STSS is doing worse than 94.09% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.57 |
3. Growth
3.1 Past
STSS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1113.75%.
EPS 1Y (TTM)-1113.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-644.21%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y99.03%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year214.37%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
STSS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for STSS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
STSS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SHARPS TECHNOLOGY INC
NASDAQ:STSS (1/8/2025, 8:00:00 PM)
2.13
-0.1 (-4.48%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners5.11%
Inst Owner Change0%
Ins Owners4.66%
Ins Owner Change0.45%
Market Cap3.83M
Analysts82.86
Price Target359.04 (16756.34%)
Short Float %7.93%
Short Ratio0.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)0
Avg Revenue beat(4)-100%
Min Revenue beat(4)-100%
Max Revenue beat(4)-100%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2100%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.59 | ||
| P/tB | 0.59 | ||
| EV/EBITDA | N/A |
EPS(TTM)-8.37
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-4.49
FCFYN/A
OCF(TTM)-4.19
OCFYN/A
SpS0
BVpS3.61
TBVpS3.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -69.94% | ||
| ROE | -120.99% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-67.22%
ROA(5y)-123.74%
ROE(3y)-106.86%
ROE(5y)-159.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 66.81% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.57 | ||
| Altman-Z | -5.62 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)2708.61%
Cap/Depr(5y)2265.16%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1113.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-644.21%
EPS Next Y99.03%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year214.37%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-23.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34.87%
OCF growth 3YN/A
OCF growth 5YN/A